Clinical Trial Update: VX-950-TiDP24-C133 - A Phase I Study Investigating the Interaction Between Telaprevir and Escitalopram [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the potential interaction between telaprevir and escitalopram in Hepatitis C patients; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Escitalopram (escitalopram)
• Telaprevir (telaprevir)

Snippet

Sponsor: Tibotec BVBA | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED